The association between allergic rhinitis and risk of rheumatoid arthritis: A systematic review and meta-analysis.
allergic rhinitis
hay fever
meta-analysis
rheumatoid arthritis
systematic review
Journal
Journal of evidence-based medicine
ISSN: 1756-5391
Titre abrégé: J Evid Based Med
Pays: England
ID NLM: 101497477
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
18
02
2020
accepted:
11
03
2020
pubmed:
17
6
2020
medline:
29
10
2021
entrez:
17
6
2020
Statut:
ppublish
Résumé
To investigate the association between allergic rhinitis (AR) and the risk of rheumatoid arthritis (RA). Potentially eligible studies were identified from MEDLINE and EMBASE databases from inception to November 2019. Eligible cohort study must report relative risk with 95% confidence intervals (95% CIs) of incident RA between AR patients and comparators. Eligible case-control studies must include cases with RA and controls without RA, and must explore their history of AR. Odds ratio with 95% CIs of the association between AR and RA must be reported. Point estimates with standard errors from each study were combined using the generic inverse variance method. A total of 21,824 articles were identified. After two rounds of the independent review by three investigators, two cohort studies and 10 case-control studies met the eligibility criteria. The pooled analysis showed no association between AR and risk of RA (RR = 0.94; 95% CI, 0.73 to 1.20; I The current systematic review and meta-analysis could not reveal a significant association between AR and RA. However, when only studies with acceptable quality were included, a significantly higher risk of RA among patients with AR than individuals without AR was observed.
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-39Informations de copyright
© 2020 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.
Références
Uhlig T, Moe RH, Kvien TK. The burden of disease in rheumatoid arthritis. PharmacoEconomics. 2014;32(9):841-851.
Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann of the Rheumatic Disea. 2014;73(7): 1316-1322.
Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094-1108.
Anderson R, Meyer PW, Ally MM, Tikly M. Smoking and Air pollution as pro-inflammatory triggers for the development of rheumatoid arthritis. Nicotine Tobacco Res. 2016;18(7):1556-1565.
Aho K, Heliovaara M. Risk factors for rheumatoid arthritis. Ann Med. 2004;36(4):242-251.
Mims JW. Epidemiology of allergic rhinitis. Int Forum Allergy Rhinol. 2014;4(S2):S18-S20.
Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81(5 Pt 2):478-518.
Zheng T, Yu J, Oh MH, Zhu Z. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3(2):67-73.
Krishna MT, Subramanian A, Adderley NJ, Zemedikun DT, Gkoutos GV, Nirantharakumar K. Allergic diseases and long-term risk of autoimmune disorders: Longitudinal cohort study and cluster analysis. Eur Respir J. 2019;54(5).
Esposito DB, Nelsen L, Hawes JCL, et al. Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients. Eur Respir J. 2014;44(Suppl 58):P3472.
Lai NS, Tsai TY, Koo M, Lu MC. Association of rheumatoid arthritis with allergic diseases: A nationwide population-based cohort study. Allergy Asthma Proc. 2015;36(5):e99-e103.
Hajdarbegovic E, Thio B, Nijsten T. Lower lifetime prevalence of atopy in rheumatoid arthritis. Rheumatol Int. 2014;34(6):847-848.
Rudwaleit M, Andermann B, Alten R, et al. Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis. 2002;61(11):968-974.
O'Driscoll BRC, Milburn HJ, Kemeny DM. Atopy and rheumatoid arthritis. Clin Allergy. 1985;15(6):547-553.
Kaptanoglu E, Akkurt I, Sahin Ö, et al. Prevalence of atopy in rheumatoid arthritis in Sivas, Turkey. A prospective clinical study. Rheumatol Int. 2004;24(5):267-271.
Hartung AD, Bohnert A, Hackstein H, Ohly A, Schmidt KL, Bein G. Th2-mediated atopic disease protection in Th1-mediated rheumatoid arthritis. Clin Exp Rheumatol. 2003;21(4):481-484.
Karatay S, Yildirim K, Ugur M, Senel K, Erdal A, Durmus B, et al. Prevalence of atopic disorders in rheumatic diseases. Modern Rheumatol. 2013;23(2):351-356.
Jeong HE, Jung SM, Cho SI. Association between rheumatoid arthritis and respiratory allergic diseases in Korean Adults: A propensity score matched case-control study. Int J Rheumatol. 2018:2018:1-8.
deRoos AJ, Cooper GS, Alavanja MC, Sandler DP. Personal and family medical history correlates of rheumatoid arthritis. Ann Epidemiol. 2008;18(6):433-439.
Olsson ÅR, Wingren G, Skogh T, Svernell O, Ernerudh J. Allergic manifestations in patients with rheumatoid arthritis. APMIS. 2003;111(10):940-944.
Sheen YH, Rolfes MC, Wi C-I, et al. Association of Asthma with rheumatoid arthritis: A population-based case-control study. J Allergy Clin Immunol Pract. 2018;6(1):219-226.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials. 1986;7(3):177-188.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557.
Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14(1):45.
Albano GD, Di Sano C, Bonanno A, et al. Th17 immunity in children with allergic asthma and rhinitis: A pharmacological approach. PLoS One. 2013;8(4):e58892-e.
vanHamburg JP, Asmawidjaja PS, Davelaar N, et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2011;63(1):73-83.
Ziolkowska M, Koc A, Luszczykiewicz G, et al. High levels of IL-17 in rheumatoid arthritis patients: iL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000;164(5):2832-2838.
Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Szypowska A, Kulus M, Demkow U. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Int Arch Allergy Immunol. 2013;162(1):16-24.
Cooles FA, Isaacs JD, Anderson AE. Treg cells in rheumatoid arthritis: An update. Curr Rheumatol Rep. 2013;15(9):352.
vanDrongelen V, Holoshitz J. Human leukocyte antigen-disease associations in rheumatoid arthritis. Rheum Dis Clin North Am. 2017;43(3):363-376.
Dhaouadi T, Sfar I, Haouami Y, et al. Polymorphisms of Toll-like receptor-4 and CD14 in systemic lupus erythematosus and rheumatoid arthritis. Biomarker Res. 2013;1(1):20.
Andiappan AK, deWang Y, Anantharaman R, Parate PN, Suri BK, Low HQ, et al. Genome-wide association study for atopy and allergic rhinitis in a Singapore Chinese population. PLoS One. 2011;6(5):e19719.
Liang XH, Cheung W, Heng CK, Wang DY. Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese. Therapeut Clin Risk Manag. 2005;1(3):243-246.
Liang XH, Cheung W, Heng CK, et al. CD14 promoter polymorphisms have no functional significance and are not associated with atopic phenotypes. Pharmacogenet Genom. 2006;16(4):229-236.
Shargorodsky J, Garcia-Esquinas E, Galán I, Navas-Acien A, Lin SY. Allergic sensitization, rhinitis and tobacco smoke exposure in US adults. PLoS One. 2015;10(7):e0131957.
Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30(11):1205-1213.